ABSTRACT
Current clinical methods used to evaluate bone quality and quantity are insufficient for clinical evaluation of microstructural bone health, which is relevant in early diagnosis of bone disease. High resolution peripheral quantitative computed tomography (HR-pQCT) has recently emerged as a potential clinical tool for quantifying volumetric bone mineral density and microarchitecture. When combined with a longitudinal imaging protocol and finite element analysis, HR-pQCT can be used to assess bone remodeling and mechanoregulation at the tissue level. Herein, 25 patients with a contralateral distal radius fracture were imaged with HR-pQCT at baseline and 9-12 months follow-up: 16 patients were prescribed Calcium and/or Vitamin D supplement with indication of diminishing (n=9) or poor (n=7) bone quantity and 9 were not. To evaluate the sensitivity of this imaging protocol to microstructural changes, HR-pQCT images were registered for quantification of bone remodeling and image-based micro-finite element (micro-FE) analysis was then used to predict local bone strains and derive rules for bone mechanoregulation. Remodeling was predicted by both trabecular and cortical thickness and bone mineral density (R2>0.8), whereas mechanoregulation was affected by dominance of the arm and group classification (p<0.05). Overall, longitudinal HR-pQCT proved value in long-term patient evaluation and management of bone health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Swiss National Science Foundation (320030L_170205), the European Union Horizon 2020 research and innovation programme under the Marie Skłodowska -Curie grant (agreement 841316), and the ETH Postdoctoral Fellowship and was supported by a grant from the Swiss National Supercomputing Centre (CSCS) under project ID s841 and s1070.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committee of the Medical University of Innsbruck (UN 0374344/4.31)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors